Search results

This study will help students determine the economic value of a firm particularly in case of a small business. The crux of the case is to help students estimate an enterprise value for a company and figure the actual worth of the company to aid in decision-making.

This case is about a decision dilemma faced by Shashi Hegde, Director, Hycons Renewable Private Ltd, a company ventured into the production of Bio-CNG. It is about a recent proposal received by the firm from APL Ltd for equity investment with 40% stake in the firm. The case reflects the dilemma faced by small businesses to choose between investment or loss of control. Accepting the proposal will bring in additional funds, whereas the Board loss control on the firm. The case revolves around this dilemma. To help Hegde in this task, he seeks advice from his CFO and his confidant Kumar.

This case is most appropriate for a core finance class for both under-graduate and graduate programs.

Teaching notes are available for educators only.

CSS 1: Accounting and Finance.

Pharmaceutical marketing, brand protection.

It could be used with the pharmaceutical marketing students and MBA students for analysing counterfeit medicines' menace in developing countries and positioning of a disruptive technology. The case could be used for marketing consultants, Brand managers and executive development programmes to explore issues such as protecting brands through technology, pharmaceutical packaging marketing, competitiveness of counterfeit drugs, global harmonisation.

Against the backdrop of rising menace of counterfeit drugs in developing countries, the case talks in particular about an innovative pharmaceutical packaging company. The company has developed a unique security technology called non-ClonableID™ which can enable products to be authenticated throughout the supply chain, thus protecting brands and preventing misuse. Despite a promising technology, it poses challenges regarding its adoption and commercial success.

Counterfeiting as an inevitable result of Globalization has become a global nuisance and has to be dealt at global level. Brand protection could be one of the lowest cost tools for pharmaceutical companies to restore public confidence in their products and themselves. While all methods for anti-counterfeiting are known to have short lives the menace still must be dealt with. For this, companies need to deploy anti-counterfeiting strategies that set up various layers of security.

Teaching note.